Virtu Financial LLC Aerie Pharmaceuticals Inc Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$6.37 - $15.23 $159,893 - $382,288	25,101 New	25,101 $380,000
Q1 2022 May 17, 2022	SELL	$5.64 - $9.8 $74,194 - $128,919	-13,155 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$7.02 - $13.33 $92,348 - $175,356	13,155 New	13,155 $92,000
Q3 2021 Nov 12, 2021	SELL	$11.32 - $16.63 $155,966 - $229,128	-13,778 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$15.16 - $18.97 $208,874 - $261,368	13,778 New	13,778 $221,000
Q3 2019 Nov 20, 2019	SELL	$18.41 - $28.0 $155,141 - $235,956	-8,427 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$28.97 - $48.21 $244,130 - $406,265	8,427 New	8,427 $249,000
Q2 2018 Jul 30, 2018	SELL	$47.85 - $70.45 $225,325 - $331,749	-4,709 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$47.85 - $70.45 $225,325 - $331,749	4,709 New	4,709 $318,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.